
Social challenges
MDNP
The EU-Latin America Mining Development Network Platform (MDNP) brings together all stakeholders from entities and disciplines related to the non-energy...
A functional cure for HIV with immunotherapy
Project dates
2017-2021
Website
Role of Zabala
partner
Project led by
IDIBAPS Y HOSPITAL CLÍNIC
14
partners
6.7 M€
total budget
37 M
people living with HIV globally
2 M
people contract HIV annually
IDIBAPS and Hospital Clínic are working on this European project that aims to change the current paradigm of HIV treatment by obtaining a functional cure. Although there are numerous prevention strategies that have given good results, they are difficult to maintain in the long term. Achieving a functional cure would leave patients carrying the virus at undetectable levels, and although prevention measures would still be necessary, the risk of transmission would be minimised. ZABALA participates in the coordination and management of this project together with 13 other European organisations.
According to the World Health Organization (WHO), 37 million people in the world are living with HIV and there are more than 2 million new infections each year. Although there are numerous successful prevention strategies, they are difficult to sustain in the long term. A functional cure for HIV is one of the major challenges in the fight against HIV.
The HIVACAR project proposes as a strategy the administration of a combination of immunotherapy that includes therapeutic vaccines (one of them personalised for each patient to prevent the escape of the virus from the vaccine), a potent antibody with the capacity to neutralise the binding site of the virus with the cells it infects and a molecule capable of reversing the latency of the virus, i.e. to unmask it.
This will be done in the framework of a Phase II clinical trial, to test its safety and tolerability. It will be determined whether this combination can activate the immune system mechanisms necessary to eliminate the infected cells from the latent viral reservoir. The socioeconomic and psychosocial impact of this treatment will also be analysed. HIVACAR will improve the quality of life of patients, reduce the current costs of HIV treatment and help control HIV replication for long periods of time or for life, without antiretroviral treatment.
This project has been financed by the European Union’s Horizon 2020 Research and Innovation programme, under grant agreement No. 731626.
“Achieving a functional cure would make patients carriers of the virus at undetectable levels.”
Laura Sesma
Senior R&D&I Consultant
Social challenges
The EU-Latin America Mining Development Network Platform (MDNP) brings together all stakeholders from entities and disciplines related to the non-energy...
Energy, Mobility
EUniversal wants to implement the universal interface concept to enable a market encompassing all actors by presenting an open approach...
Climate, Natural Resources and Environment
RUBIZMO aims to stimulate investments in various rural economic sectors, with a special focus on the valorisation of rural assets...
News
Opinion
THIRD COUNTRIES
Paola Votta
EU Project Manager
Publication
INNOVATION FUND
Do you want to present your project with a chance of success to the Innovation Fund (IF)? Our team of experts has developed this guide to help you understand how to submit your large-scale project
The important thing is not to keep moving, but rather to know in which direction to go. Our 37% success rate proves that we know how to guide our clients.
Our compass is our clients; our mission is to solve their problems, guiding them so that innovation becomes their key to competitiveness.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.